Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Complications of MRI-guided stereotactic biopsy of brain lymphoma

H. Malikova, R. Liscak, I. Latnerova, K. Guseynova, M. Syrucek, R. Pytlik,

. 2014 ; 35 (7) : 613-8.

Jazyk angličtina Země Švédsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15013939

OBJECTIVES: Stereotactic biopsy is a suitable method for sampling intrinsic brain lesions. Although this method is considered to be a safe procedure, some risk of complications still exists. The aim of the study was to retrospectively assess the morbidity and mortality of MRI-guided stereotactic biopsy of lesions which were histologically proven to be brain lymphoma. METHODS: We retrospectively studied all accessible medical records for patients who had undergone MRI-guided stereotactic biopsy of brain lesions with histologically proven brain lymphoma from January 2007 to December 2012. Our cohort included 45 patients, 27 males and 18 females, aged 23-84 (63±14) years. RESULTS: Forty-nine biopsies were carried out on 45 patients; the average number of tissue specimens was 3±1. The diagnostic yield of the stereotactic biopsy was 92%. Overall major morbidity directly related to stereotactic biopsy of brain lymphoma was 6.1% (3 cases) including 4.1% mortality (2 cases). Both deaths after the stereotactic procedure were due to intracranial hemorrhage and subsequent complications and both these patients had a history of treatment of systemic lymphomas. In one patient the stereotactic biopsy was complicated by a brain abscess which was successfully treated. CONCLUSION: Stereotactic biopsy is still a mandatory diagnostic procedure for primary brain lymphomas, with an acceptable risk of complications. However, according to our results, the risk of complications can be higher in patients who have previously been treated for secondary lymphomas.

000      
00000naa a2200000 a 4500
001      
bmc15013939
003      
CZ-PrNML
005      
20150421095113.0
007      
ta
008      
150420s2014 sw f 000 0|eng||
009      
AR
035    __
$a (PubMed)25617885
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Malikova, Hana $u Department of Radiology, Na Homolce Hospital, Prague, Czech Republic.
245    10
$a Complications of MRI-guided stereotactic biopsy of brain lymphoma / $c H. Malikova, R. Liscak, I. Latnerova, K. Guseynova, M. Syrucek, R. Pytlik,
520    9_
$a OBJECTIVES: Stereotactic biopsy is a suitable method for sampling intrinsic brain lesions. Although this method is considered to be a safe procedure, some risk of complications still exists. The aim of the study was to retrospectively assess the morbidity and mortality of MRI-guided stereotactic biopsy of lesions which were histologically proven to be brain lymphoma. METHODS: We retrospectively studied all accessible medical records for patients who had undergone MRI-guided stereotactic biopsy of brain lesions with histologically proven brain lymphoma from January 2007 to December 2012. Our cohort included 45 patients, 27 males and 18 females, aged 23-84 (63±14) years. RESULTS: Forty-nine biopsies were carried out on 45 patients; the average number of tissue specimens was 3±1. The diagnostic yield of the stereotactic biopsy was 92%. Overall major morbidity directly related to stereotactic biopsy of brain lymphoma was 6.1% (3 cases) including 4.1% mortality (2 cases). Both deaths after the stereotactic procedure were due to intracranial hemorrhage and subsequent complications and both these patients had a history of treatment of systemic lymphomas. In one patient the stereotactic biopsy was complicated by a brain abscess which was successfully treated. CONCLUSION: Stereotactic biopsy is still a mandatory diagnostic procedure for primary brain lymphomas, with an acceptable risk of complications. However, according to our results, the risk of complications can be higher in patients who have previously been treated for secondary lymphomas.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a biopsie $x škodlivé účinky $x mortalita $7 D001706
650    _2
$a nádory mozku $x mortalita $x patologie $7 D001932
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lymfom $x mortalita $x patologie $7 D008223
650    _2
$a magnetická rezonanční tomografie $x metody $x mortalita $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a morbidita $7 D009017
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a rizikové faktory $7 D012307
650    _2
$a stereotaktické techniky $x škodlivé účinky $x mortalita $7 D013238
650    _2
$a analýza přežití $7 D016019
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Liscak, Roman $u Department of Stereotactic Neurosurgery, Na Homolce Hospital, Prague, Czech Republic.
700    1_
$a Latnerova, Iva $u Department of Radiology, Na Homolce Hospital, Prague, Czech Republic.
700    1_
$a Guseynova, Khumar $u Department of Stereotactic Neurosurgery, Na Homolce Hospital, Prague, Czech Republic.
700    1_
$a Syrucek, Martin $u Department of Pathology, Na Homolce Hospital, Prague, Czech Republic.
700    1_
$a Pytlik, Robert $u 1st Faculty of Internal Medicine, 1st Medical Faculty, Charles University, Prague, Czech Republic.
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 35, č. 7 (2014), s. 613-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25617885 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20150421095411 $b ABA008
999    __
$a ok $b bmc $g 1071520 $s 896817
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 35 $c 7 $d 613-8 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$a Pubmed-20150420

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace